NEPHROLITHIASIS

This adverse event was reported 45914 times

These drugs are most commonly taken by patients reporting NEPHROLITHIASIS:

# Drug Count
0 ADALIMUMAB 3242
1 PREDNISONE 2685
2 ACETAMINOPHEN 2260
3 METHOTREXATE SODIUM 2252
4 OMEPRAZOLE MAGNESIUM 2077
5 METHOTREXATE 2066
6 ETANERCEPT 1962
7 ASPIRIN 1930
8 ASPIRIN 325 MG 1857
9 ASPIRIN 81 MG 1857
See all common drugs associated with NEPHROLITHIASIS

NEPHROLITHIASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALMOTRIPTAN 373 0.3526
1 DIHYDROERGOTAMINE MESYLATE 252 0.1871
2 LUMASIRAN 38 0.0984
3 POTASSIUM CITRATE 279 0.0501
4 MEPERIDINE HYDROCHLORIDE 434 0.0464
5 RIZATRIPTAN BENZOATE 470 0.0455
6 KETAMINE HYDROCHLORIDE 194 0.0378
7 TIOPRONIN 93 0.0373
8 ATAZANAVIR 474 0.0331
9 ALENDRONATE SODIUM AND CHOLECALCIFEROL 91 0.0328
See all drugs enriched for association with NEPHROLITHIASIS

NEPHROLITHIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 176 0.2558
1 Provitamin D2 Compound [EPC] 2372 0.0797
2 Guanylate Cyclase-C Agonist [EPC] 107 0.0516
3 Reducing and Complexing Thiol [EPC] 93 0.0373
4 Adrenocorticotropic Hormone [EPC] 26 0.0291
5 Plasma Kallikrein Inhibitor [EPC] 54 0.0225
6 Interleukin-17A Antagonist [EPC] 798 0.0214
7 Urease Inhibitor [EPC] 1 0.0213
8 Human Immunoglobulin G [EPC] 391 0.0186
9 GLP-2 Analog [EPC] 234 0.0174
See all drug classes enriched for association with NEPHROLITHIASIS